Understanding and Improving Quality of Life Through a Wireless Activity Tracker: Observational Phase
Status: | Completed |
---|---|
Conditions: | Brain Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - 99 |
Updated: | 3/22/2019 |
Start Date: | September 2014 |
End Date: | September 2018 |
This project attempts to correlate wireless activity data with quality of life and sleep
surveys in order to find a new method of monitoring patients during their treatment.
surveys in order to find a new method of monitoring patients during their treatment.
This project proposes the investigation, validation, and use of a wireless activity tracker
to better understand and improve the quality of life of patients suffering from brain tumors.
The Fitbit flex wireless syncing activity tracker will be distributed to 75 patients, and the
electronic infrastructure to automatically track patients will be created and adapted for the
cohort. Surveys will routinely assess the ease-of-use and any problems arising. This
heterogenous population of patients suffering from brain tumors will be tracked and compared
through routine evaluation of their quality of life through well-established surveys,
including the SF-36 and FACT-Br. The association between data recorded from the activity
tracker and the QOL surveys will be quantified to validate the activity tracking data as a
surrogate measure of part, if not all, of QOL as well as sleep.
to better understand and improve the quality of life of patients suffering from brain tumors.
The Fitbit flex wireless syncing activity tracker will be distributed to 75 patients, and the
electronic infrastructure to automatically track patients will be created and adapted for the
cohort. Surveys will routinely assess the ease-of-use and any problems arising. This
heterogenous population of patients suffering from brain tumors will be tracked and compared
through routine evaluation of their quality of life through well-established surveys,
including the SF-36 and FACT-Br. The association between data recorded from the activity
tracker and the QOL surveys will be quantified to validate the activity tracking data as a
surrogate measure of part, if not all, of QOL as well as sleep.
Inclusion Criteria:
- diagnosed with primary or metastatic brain tumor
- able to wear wireless activity tracker
- able to complete QOL and sleep surveys every 3 months
Exclusion Criteria:
- unable to provide consent
- age < 18
- lack of use of the wireless activity tracker for more than 2 consecutive months
We found this trial at
1
site
Minneapolis, Minnesota 55455
(612) 625-5000
Principal Investigator: David Darrow, MD MPH
Phone: 612-624-6666
Univ of Minnesota With a flagship campus in the heart of the Twin Cities, and...
Click here to add this to my saved trials